Florida

Florida House Bill 389 Testing for and Treatment of Influenza and Streptococcus was heard on January 15th in the House Health Care Appropriation Subcommittee. The bill passed favorably with a vote of 10-1. The next stop is the House Health and Human Services.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2020-01-16T10:08:17-05:00January 16, 2020|Florida|

Florida

HB 389, Testing for and Treatment of Influenza and Streptococcus, was heard on November 13 in the House Health Quality Subcommittee. The bill passed favorably with a vote of 11-3, next stop is the House Health Care Appropriations Committee.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2019-12-12T09:50:01-05:00December 12, 2019|Florida|

Florida

HB 389Testing for and Treatment of Influenza and Streptococcuswas heard on November 13 in the House Health Quality Subcommittee. The bill passed favorably with a vote of 11-3, next stop is the House Health Care Appropriations Committee.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2019-11-21T12:06:55-05:00November 21, 2019|Florida|

Florida

Effective Tuesday, October 1, IngenioRx, Inc. (IngenioRx) will begin to administer the prescription benefits for Simply Healthcare of Florida Inc. (Simply) Comprehensive Plan and Clear Health Alliance Specialty Plans. Members may be transitioned to a network pharmacy with IngenioRx that continues to meet member access requirements.

Providers that are out of network as of Tuesday, October 1 will be eligible for a 60-day continuity of care period where claims will be payable to allow time for members to transition to a new pharmacy, if necessary. All members were notified of this transition by mail on August 2. The continuity of care period ends on Saturday, November 30.

The pharmacy claim processing information to IngenioRx for Simply Comprehensive Plan and Clear Health Alliance Specialty Plan is noted below:

RXBIN:   020107
RXPCN:   CH
RXGRP:   WK3A
Member ID Format: 11-14 digits

For questions regarding future network or contract related inquiries, call IngenioRx at 1-833-235-2030.

Prior to Tuesday, October 1, providers may contact Simply Provider Services for eligibility or prior authorization questions at 1-877-577-9044.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2019-09-19T12:14:39-04:00September 19, 2019|Florida|

Florida

Effective Monday, March 18, Medicaid paper exceptional claims will no longer be accepted. Providers must submit an exceptional claim, along with the required Exceptional Claim Form, electronically via the newly redesigned Florida Medicaid Secure Web Portal under the Claims panel. Providers are encouraged to review the Electronic Exceptional Claim Submission Quick Reference Guide.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2019-03-19T13:19:19-04:00March 8, 2019|Florida|

Florida

Effective Thursday, July 5, the final rule of the Department of Health, Board of Pharmacy, amends regulations under FAC 64B16-28 regarding requirements for use of automated pharmacy systems (APS) in community pharmacies. The rule specifies that pharmacies may use an APS if system operation is under the supervision of a pharmacist or is located within the prescription department, adjacent to the prescription department or on the establishment of the licensed pharmacy. The rule also specifies that the system must include a mechanism to ensure that the patient or an authorized agent of the patient can communicate with a pharmacist responsible for dispensing the medical drug product. In addition, the rule revises additional requirements for patient accessed automated pharmacy systems.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2018-06-29T09:17:46-04:00June 28, 2018|Florida|

Florida

Medicaid will host a conversation with staff from the state’s Prescription Drug Monitoring Program known as E-FORCSE to provide insights into the new program requirements and opportunities following passage of HB 21. The webinar will be held on Tuesday, June 12 at 12:00 p.m. EDT. Register online after which you will receive an email confirmation. Please send questions to Medicaid staff.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2018-06-08T08:42:53-04:00June 7, 2018|Florida|

Florida

Last fall, CMS approved the State Plan Amendment (SPA) for a new Medicaid fee-for-service reimbursement methodology. Subsequently, the Agency for Health Care Administration promulgated a final rule consistent with the approved SPA. Medicaid will begin reimbursing pharmacy providers using the new methodology on Friday, June 15. A subsequent provider alert will outline the plan for scheduling the reprocessing of pharmacy claims retroactive to April 1, 2017 in order to comply with the approved SPA.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2018-05-25T10:42:18-04:00May 17, 2018|Florida|

Florida

On February 7, 2018, the Board of Pharmacy proposed a change to rule 64B16-27.630 to add Meningococcal B (MedB) and Zoster Vaccine Recombinant, Adjuvanted. The final rule is effective Thursday, April 12, 2018.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2018-04-25T11:04:54-04:00April 5, 2018|Florida|
Go to Top